CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 57 filers reported holding CTI BIOPHARMA CORP in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,570,000 | +32.0% | 850,000 | +88.9% | 1.98% | +44.3% |
Q4 2022 | $2,704,500 | +8.8% | 450,000 | +5.4% | 1.37% | +50.8% |
Q3 2022 | $2,485,000 | +77.5% | 427,000 | +42.4% | 0.91% | +94.2% |
Q1 2022 | $1,400,000 | -74.2% | 299,800 | -86.3% | 0.47% | -68.6% |
Q4 2021 | $5,419,000 | -44.6% | 2,185,000 | -34.0% | 1.49% | -41.7% |
Q3 2021 | $9,773,000 | +6.3% | 3,313,000 | -9.9% | 2.56% | +20.2% |
Q2 2021 | $9,197,000 | +436.6% | 3,678,677 | +524.6% | 2.13% | +348.1% |
Q1 2021 | $1,714,000 | -9.6% | 588,992 | 0.0% | 0.48% | -32.8% |
Q4 2020 | $1,897,000 | – | 588,992 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|